Physician

Andrew William Varga, MD/PHD

According to 2025 Medicare claims, Andrew Varga, MD/PHD (NPI: 1639316623) practices sleep medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NPI: 1518228550; TIN: 611661781) and primary practice location at 10003-3314. Varga is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Varga's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 83 traditional Medicare patients, billed 91 HCPCS/CPT codes, and received $7,444 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 334 prescription claims across 47 beneficiaries totaling $53,691 in drug costs, led by Dayvigo (Lemborexant). DME data shows 506 claims. Open Payments data shows 9 records totaling $914. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $19,999 to $7,444. In contrast, Part D prescription costs have risen steadily, from $4,311 to $53,691. For DME billing, reported payments moved sharply higher in recent years, from $3,074 to $20,834.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	67	86	$19,999
2017	98	122	$33,369
2018	89	124	$18,456
2019	81	102	$7,759
2020	64	84	$6,530
2021	93	116	$11,329
2022	97	118	$10,521
2023	78	91	$8,020
2024	83	91	$7,444

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	19	$4,311
2017	15	49	$6,154
2018	28	102	$3,916
2019	21	117	$7,694
2020	20	107	$5,718
2021	26	158	$11,349
2022	37	243	$20,741
2023	45	303	$24,914
2024	47	334	$53,691

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$342
2016	N/R	88	$2,302
2017	136	287	$8,467
2018	174	354	$9,326
2019	175	379	$11,619
2020	274	517	$17,013
2021	264	476	$18,190
2022	242	512	$18,215
2023	262	553	$20,532
2024	233	506	$20,010

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	14	14	$105
95810	Sleep study in sleep lab (6 years or older)	13	13	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	58	60	$71

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dayvigo	Lemborexant	41	1,350	$14,813
Belsomra	Suvorexant	28	840	$12,426
Doxepin Hcl	Doxepin Hcl	30	900	$3,178
Eszopiclone	Eszopiclone	11	330	$703
Pregabalin	Pregabalin	28	840	$597

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	26	66	$3,362
A7032	Cushion for use on nasal mask interface, replacement only, each	N	14	29	$2,904
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	33	74	$2,704
A7031	Face mask interface, replacement for full face mask, each	N	11	26	$2,397
A7030	Full face mask used with positive airway pressure device, each	N	11	28	$2,358

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$914	Avadel CNS Pharmaceuticals, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew William Varga, MD/PHD?

Tedicare shows public-source Medicare data for Andrew William Varga, MD/PHD (NPI 1639316623), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew William Varga, MD/PHD have ACO affiliation data?

Andrew William Varga, MD/PHD is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Andrew William Varga, MD/PHD?

Andrew William Varga, MD/PHD is linked to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (billing NPI 1518228550) in the available physician profile data.

Does Andrew William Varga, MD/PHD have Open Payments data?

Andrew William Varga, MD/PHD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.